Medtronic’s sales took a 4% hit in the second quarter, which the company attributes to the impact of Hurricane Maria on its operations in Puerto Rico, as well as the divestiture of a trio of businesses to Cardinal Health.
Alembic Pharmaceuticals reported a 1.44 per cent increase in consolidated net profit at Rs 121.56 crore for the second quarter ended September 30, mainly on account of decline in total income.
Drug firm GlaxoSmithKline Pharmaceuticals today reported a 31.83 per cent rise in standalone net profit to Rs 130.32 crore for the second quarter ended September 30, 2017.